Adriamycin affects plasma membrane redox functions.
D000818:Animals; D001204:Ascorbate Oxidase / Q000378:metabolism; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000494:pharmacology*; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000378:metabolism*; D004912:Erythrocytes / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D008099:Liver / Q000378:metabolism*; D051379:Mice; D009245:NADH Dehydrogenase / Q000378:metabolism; D010084:Oxidation-Reduction; D051381:Rats; D013482:Superoxide Dismutase / Q000494:pharmacology; D013552:Swine; D014639:Vanadium / Q000494:pharmacology
D014639:Vanadium; D004317:Doxorubicin; D001204:Ascorbate Oxidase; D013482:Superoxide Dismutase; D009245:NADH Dehydrogenase